Outcome of patients with relapsed or refractory anaplastic large cell lymphoma who have failed brentuximab vedotin

Hematological Oncology,Volume 0, Issue ja, -Not available-.

Source: Hematological Oncology - September 13, 2018 Category: Hematology Authors: DaiChihara , ShannonWong , TatyanaFeldman , Michelle A.Fanale , LarysaSanchez , Joseph M.Connors , Kerry J.Savage , YasuhiroOki Source Type: research